Please assess the completion status of the following clinical trial:

Trial Title: Molecular Biomarkers for Sepsis

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Admission to the ICU of one of the participating centers.~* Cases: severe community acquired pneumonia with requirement for ICU admission.~* Controls: Clinical phenotype of inflammation not due to suspected sepsis In addition, control patients will be patients with fever \>38°C, CRP \>100mg/L, no infection focus expected in ≥ 24h.~* All required sample types can most likely be collected within the first 24h visits.~* Expected ICU stay of more than 24h.~Exclusion Criteria:~* Admission to the hospital within the prior 14 days.~* Patients with psychosis~* Evidence of a hospital acquired pneumonia.~* One of the following respiratory conditions: Acute exacerbation of chronic obstructive pulmonary disease (COPD) or bronchiectasis, acute severe asthma, aspiration pneumonia, tuberculosis, clinical suspected viral pneumonia without bacterial infection, cardiogenic pulmonary oedema.~* Patients with an acute respiratory distress Syndrome (ARDS).~* Patient which can be managed as outpatients and do not require an ICU.~* Patient where a transmission to another institution is likely within the next 24h.~* Documented rejection of the general consent or participation to research in general.~* Patients with a palliative situation and a life expectancy due to other diseases (e.g. progressed cancer) less than 28 days.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- patients with severe community acquired pneumonia (cases) (Type: None): Cases: Patients with severe community acquired pneumonia with required ICU admission.
- patients without pneumonia or sepsis (controls) (Type: None): Controls: Clinical phenotype of inflammation not due to suspected sepsis; patients with fever \>38°C, C reactive Protein (CRP) \>100mg/L, no infection focus expected in ≥ 24h.

Based on this trial design, predict the completion outcome and termination type (if applicable).